Transcarent Raises $58M in Series B Funding


Transcarent, a San Francisco, CA-based consumer-directed health and care experience for employees of self-insured employers and their families, raised $58m in Series B funding.

The round, which brought total funding to $98m, was led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps byBayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners.

The company intends to use the funds to expand its risk-based offering for self-insured employers.

Launched in March 2021 by Glen Tullman, CEO, Transcarent is a health and care experience company that delivers a personalized, 24/7 care experience, addressing virtually all of the most common and most challenging issues a person faces by connecting them with a personal Health Guide or physician, offering expert second opinions, medication review and management, virtual physical therapy, and comprehensive appropriate site-of-care surgery solutions.